Velcade and aspartate aminotransferase increased Patient Reports March 15, 2010

Velcade Side Effects Report #4618415-5
Velcade side effect was reported by a Physician from on Mar 10, 2005. Female patient, 65 years of age, weighting 145.5 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin increased, blood calcium decreased, blood immunoglobulin a decreased, blood immunoglobulin g decreased, blood immunoglobulin m decreased, blood lactate dehydrogenase increased, decreased appetite. Velcade dosage: unknown. During the same period patient was treated with ZOMETA, ERYTHROPOIETIN, MORPHINE SULPHATE, ALLOPURINOL, PANTOPRAZOLE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5654436-1
Velcade side effect was reported by a Health Professional from UNITED STATES on Feb 27, 2008. Female patient, 79 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, fatigue, hypoglycaemia, liver function test abnormal, nausea

, pancytopenia. Velcade dosage: 3.08 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA, GLYBURIDE, GEMFIBROZIL, AVALIDE, PREVACID, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5677942-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2008. Female patient, 79 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, fatigue, hypoglycaemia, liver function test abnormal, nausea

, neutropenia. Velcade dosage: 3.08 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA, GLYBURIDE, GEMFIBROZIL, AVALIDE, PREVACID, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5691648-5
Velcade side effect was reported by a Health Professional from UNITED STATES on Mar 21, 2008. Female patient, 79 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose abnormal, fatigue, fungal infection

, hypoglycaemia, liver function test abnormal, nausea

. Velcade dosage: 2.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ALIMTA, GLYBURIDE, GEMFIBROZIL, AVALIDE, PREVACID, CIPROFLOXACIN, AMBIEN, VICODIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5706446-3
Velcade side effect was reported by a Health Professional from UNITED STATES on Apr 02, 2008. Female patient, 79 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood glucose increased, fatigue, fungal infection

, hypoglycaemia, liver function test abnormal. Velcade dosage: 2.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ALIMTA, GLYBURIDE, GEMFIBROZIL, AVALIDE, PREVACID, CIPROFLOXACIN, AMBIEN, VICODIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4986498-9
Velcade side effect was reported by a Physician from UNITED STATES on Apr 12, 2006. Male patient, 40 years of age, weighting 162.0 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal discomfort, alanine aminotransferase increased, aspartate aminotransferase increased, chest discomfort, dehydration, nausea

. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with ALIMTA, OXYCONTIN, MEGACE, ATIVAN, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4903630-3
Velcade side effect was reported by a Physician from UNITED STATES on Jan 19, 2006. Male patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, beta 2 microglobulin increased, blood glucose increased, cholelithiasis, herpes zoster disseminated, inflammation, malignant neoplasm progression, non-hodgkin's lymphoma, platelet count decreased. Velcade dosage: 3.20 MG. During the same period patient was treated with SYNTHROID, AVAPRO, LORAZEPAM, VANCOMYCIN, FLAGYL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5427669-7
Velcade side effect was reported by a Physician from JAPAN on Aug 06, 2007. Male patient, 71 years of age, weighting 105.8 lb, was diagnosed with multiple sclerosis

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, aspergillosis, basophil count decreased, blood alkaline phosphatase decreased, blood immunoglobulin g increased, blood lactate dehydrogenase increased, blood urea decreased, blood urea increased. Velcade dosage: 1.00 MG/M2, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE. Patient died on 05/07/2007.

Velcade Side Effects Report #5678784-4
Velcade side effect was reported by a Physician from UNITED STATES on Mar 11, 2008. Male patient, 86 years of age, weighting 164.0 lb, was diagnosed with multiple myeloma

, decreased appetite, dysstasia, fall

, haemarthrosis. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with REVLIMID, DEXAMETHASONE, COUMADIN, ZOFRAN, POTASSIUM CHLORIDE, VITAMIN E, PROTONIX, ULTRAM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5984815-4
Velcade side effect was reported by a Physician from JAPAN on Nov 20, 2008. Male patient, 78 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, disease progression, gastrointestinal haemorrhage, hyperkalaemia, hypotension. Velcade dosage: 1.5 MG, INTRAVENOUS. During the same period patient was treated with CANDESARTAN CILEXETIL, ALLOPURINOL, KAYEXALATE, MOBIC, METHYCOBAL, PURSENNID, OXYCONTIN, MAGNESIUM OXIDE. Patient died on 10/15/2008.

Velcade Side Effects Report #6034985-7
Velcade side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 78 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood amylase increased, cerebellar haemorrhage, depression

, disseminated intravascular coagulation, fall

, hypertension, sepsis

. Velcade dosage: 1.5 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PAXIL, LEUCOCYTE POOR RED CELLS, ITRACONAZOLE, MAXIPIME, NEUTROGIN, PLATELETS, ORGARAN. Patient died on 09/27/2007.

Velcade Side Effects Report #4758752-7
Velcade side effect was reported by a Pharmacist from UNITED STATES on Aug 12, 2005. Male patient, 78 years of age, weighting 202.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: angina pectoris, anisocytosis, aspartate aminotransferase increased, blood creatine increased, cardiac failure congestive, cardiac murmur, cardiomegaly, fluid retention, haematocrit decreased. Velcade dosage: 2.60 MG, 2/WEEK, IV BOLUS. During the same period patient was treated with NEXIUM, FUROSEMIDE, ZOMETA, PREDNISONE, GLUCOCORTICOIDS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4766717-4
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2005. Male patient, 77 years of age, weighting 159.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: amnesia, aspartate aminotransferase increased, bilirubin conjugated increased, blood albumin decreased, blood bilirubin increased, blood calcium decreased, brain natriuretic peptide increased, confusional state, dehydration. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CRESTOR, LOTENSIN, INSULIN, DURAGESIC, PROTONIX, MOBIC, VITAMIN C. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4778188-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 07, 2005. Male patient, 77 years of age, weighting 159.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood albumin decreased, blood bilirubin increased, blood calcium decreased, blood chloride decreased, blood potassium increased, brain natriuretic peptide increased, cardiac failure congestive. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CRESTOR, LOTENSIN, INSULIN, IRON, DURAGESIC, PROTONIX, MOBIC, VITAMIN C. Patient was hospitalized. Patient died on 08/26/2005.

Velcade Side Effects Report #5218368-5
Velcade side effect was reported by a Physician from SPAIN on Jan 10, 2007. Male patient, 75 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bone marrow failure, cardiac failure, encephalopathy, hepatotoxicity, klebsiella bacteraemia, nerve root compression, neuropathy peripheral. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5989301-3
Velcade side effect was reported by a Physician from JAPAN on Nov 25, 2008. Female patient, 74 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #6023767-8
Velcade side effect was reported by a Physician from JAPAN on Dec 12, 2008. Female patient, 74 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #6050681-4
Velcade side effect was reported by a Physician from JAPAN on Jan 08, 2009. Female patient, 74 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with SUCRALFATE, LAC B, MAGNESIUM OXIDE, FAMOTIDINE, LOXONIN, ASPARA K, LEVOFLOXACIN. Patient recovered.

Velcade Side Effects Report #5371454-1
Velcade side effect was reported by a Physician from UNITED STATES on June 12, 2007. Male patient, 73 years of age, weighting 177.0 lb, was diagnosed with multiple myeloma

, deep vein thrombosis

, diverticulum. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with DOXIL, DECADRON, ARANESP, ALOXI, CHLORIDE, ZOMETA, DARVOCET, CALCIUM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6023756-3
Velcade side effect was reported by a Physician from JAPAN on Dec 12, 2008. Female patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, c-reactive protein increased, capillary leak syndrome, constipation

, hyperphosphatasaemia, pyrexia, thrombocytopenia, tumour lysis syndrome. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LAXOBERON, SENNOSIDE A, SORBITOL, LECICARBON, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6050733-9
Velcade side effect was reported by a Physician from JAPAN on Jan 08, 2009. Female patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma

, hyperphosphatasaemia, hyponatraemia, hypotension, non-cardiogenic pulmonary oedema. Velcade dosage: 1.8 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LAXOBERON, SENNOSIDE A, SORBITOL, LECICARBON, MAGNESIUM OXIDE, DOPAMINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6111536-X
Velcade side effect was reported by a Physician from ITALY on Feb 25, 2009. Female patient, 73 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, atrial fibrillation

, blood lactate dehydrogenase increased. Velcade dosage: 2.23 MG. During the same period patient was treated with DEXAMETHASONE, METOPROLOL TARTRATE, EUTIROX, ZANTAC, TRAMADOL, CARDIOASPRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6125896-7
Velcade side effect was reported by a Physician from ITALY on Mar 08, 2009. Female patient, 73 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, atrial fibrillation

, blood lactate dehydrogenase increased, cardiac disorder, muscle disorder

. Velcade dosage: 2.2 MG,. During the same period patient was treated with DEXAMETHASONE, METOPROLOL TARTRATE, EUTIROX, ZANTAC, TRAMADOL, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4629498-0
Velcade side effect was reported by a Physician from on Mar 24, 2005. Male patient, 73 years of age, weighting 231.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aspartate aminotransferase increased, blood albumin decreased, blood magnesium decreased, blood urea decreased, circulatory collapse, confusional state, creatine phosphokinase decreased, neuropathy peripheral. Velcade dosage: 3.00 MG, INTRAVENOUS; 2.30 MG, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, AMLODIPINE. Patient recovered.

Velcade Side Effects Report #4633331-0
Velcade side effect was reported by a Physician from on Mar 24, 2005. Male patient, 73 years of age, weighting 231.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood magnesium decreased, circulatory collapse, confusional state, decreased activity, neuropathy peripheral, paraesthesia, platelet count decreased, white blood cell count decreased. Velcade dosage: 3.00 MG, INTRAVENOUS; 2.30 MG, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, AMLODIPINE. Patient recovered.

Velcade Side Effects Report #4878071-8
Velcade side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Dec 26, 2005. Male patient, 72 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase abnormal, aspartate aminotransferase increased, blood albumin decreased, condition aggravated, haemodialysis, haemoglobin abnormal, hypotension, labile blood pressure, platelet disorder. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with BETAMETHASONE. Patient was hospitalized. Patient died on 08/01/2003.

Velcade Side Effects Report #5353547-8
Velcade side effect was reported by a Physician from JAPAN on June 01, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood potassium decreased, blood urea increased, blood uric acid increased, c-reactive protein increased, hypotension, lymphopenia. Velcade dosage: 2.00 MG. During the same period patient was treated with DEXAMETHASONE, OMEPRAL, GANATON, DEPAS, NOVAMIN, GOSHAJINKIGAN, SULFAMETHOXAZOLE. Patient died on 05/31/2007.

Velcade Side Effects Report #5466072-0
Velcade side effect was reported by a Physician from JAPAN on Sept 10, 2007. Male patient, 71 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, basophil count decreased, blood alkaline phosphatase decreased, blood glucose increased, blood urea increased, blood uric acid increased, computerised tomogram thorax abnormal, condition aggravated. Velcade dosage: 1.00 MG/M2; INTRAVENOUS, 1.40 MG; INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE. Patient died on 05/07/2007.

Velcade Side Effects Report #5491279-6
Velcade side effect was reported by a Physician from JAPAN on Oct 05, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood potassium decreased, blood urea increased, blood uric acid increased, c-reactive protein increased, hypotension, lymphopenia. Velcade dosage: 2.00 MG,. During the same period patient was treated with DEXAMETHASONE, OMEPRAL, GANATON, DEPAS, NOVAMIN, GOSHAJINKIGAN, BAKTAR. Patient died on 05/31/2007.

Velcade Side Effects Report #5533895-9
Velcade side effect was reported by a Physician from JAPAN on Nov 13, 2007. Male patient, 71 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, basophil count decreased, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea decreased, blood urea increased, blood uric acid increased, c-reactive protein increased. Velcade dosage: 1.00 MG/M2, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE. Patient died on 05/07/2007.

Velcade Side Effects Report #5615693-0
Velcade side effect was reported by a Physician from JAPAN on Jan 22, 2008. Male patient, 71 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, basophil count decreased, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, c-reactive protein increased, febrile neutropenia. Velcade dosage: 1.00 MG/M2, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE. Patient died on 05/07/2007.

Velcade Side Effects Report #5746163-7
Velcade side effect was reported by a Physician from JAPAN on May 08, 2008. Male patient, 71 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood uric acid increased, diarrhoea, eosinophilia, gait disturbance, hypoaesthesia, hypokalaemia. Velcade dosage: 2 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with GLYBURIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6029384-8
Velcade side effect was reported by a Physician from JAPAN on Dec 25, 2008. Male patient, 71 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood urea increased, diarrhoea, gait disturbance, hypoaesthesia, hypokalaemia, platelet count decreased, renal failure. Velcade dosage: 2 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with GLYBURIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5954226-6
Velcade side effect was reported by a Physician from JAPAN on Oct 31, 2008. Male patient, 70 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, asthenia, blood calcium decreased, blood chloride increased, blood lactate dehydrogenase increased, blood urea increased, bone marrow disorder, disease progression, gastrointestinal haemorrhage. Velcade dosage: 1.9 MG, UNK, INTRAVENOUS. During the same period patient was treated with CEFTAZIDIME, RED BLOOD CELLS. Patient died on 12/26/2006.

Velcade Side Effects Report #4805526-4
Velcade side effect was reported by a Physician from UNITED STATES on Oct 04, 2005. Male patient, 70 years of age, weighting 121.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abasia, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, asthenia, confusional state, dyspnoea exertional, fatigue, performance status decreased. Velcade dosage: 2.00 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL, LACTULOSE, MORPHIEN SULPHATE, MS CONTIN, PAMIDRONATE DI. Patient was hospitalized. Patient died on 09/28/2005.

Velcade Side Effects Report #5298336-8
Velcade side effect was reported by a Physician from JAPAN on Apr 03, 2007. Female patient, 69 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, leukopenia, pyrexia, thrombocytopenia. Velcade dosage: 1.70 MG. During the same period patient was treated with PIPERACILLIN, FAMOTIDINE, MAGNESIUM OXIDE, ADALAT, ISOSORBIDE MONONITRATE, SIMVASTATIN, MOBIC, BAKTAR. Patient recovered.

Velcade Side Effects Report #5367277-X
Velcade side effect was reported by a Physician from JAPAN on June 07, 2007. Female patient, 69 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, leukopenia, pyrexia, thrombocytopenia. Velcade dosage: 1.70 MG. During the same period patient was treated with PIPERACILLIN, FAMOTIDINE, MAGNESIUM OXIDE, ADALAT, ISOSORBIDE MONONITRATE, SIMVASTATIN, MOBIC, SULFAMETHOXAZOLE. Patient recovered.

Velcade Side Effects Report #5387598-4
Velcade side effect was reported by a Physician from JAPAN on June 29, 2007. Female patient, 69 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, leukopenia, pyrexia, thrombocytopenia. Velcade dosage: 1.70 MG. During the same period patient was treated with PIPERACILLIN, FAMOTIDINE, MAGNESIUM OXIDE, ADALAT, ISOSORBIDE MONONITRATE, SIMVASTATIN, MOBIC, SULFAMETHOXAZOLE. Patient recovered.

Velcade Side Effects Report #5822673-9
Velcade side effect was reported by a Physician from JAPAN on July 10, 2008. Female patient, 69 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, faecal incontinence, herpes zoster, leukopenia, malaise, oedema peripheral, platelet count decreased, pyrexia. Velcade dosage: 1.7 MG; 1.3 MG, INTRAVENOUS; 1.7 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, PIPERACILLIN, FAMOTIDINE, MAGNESIUM OXIDE, ADALAT. Patient recovered.

Velcade Side Effects Report #6106578-4
Velcade side effect was reported by a Physician from JAPAN on Feb 20, 2009. Female patient, 69 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, bone pain, faecal incontinence, herpes zoster, leukopenia, malaise, oedema peripheral. Velcade dosage: 1.7 MG UNK UNK; 1.3 MG UNK INTRAVENOUS; 1.7 MG UNK INTRAVENOUS; 1.5 MG UNK INTRAVENOUS. During the same period patient was treated with ZOMETA, PIPERACILLIN, FAMOTIDINE, MAGNESIUM OXIDE, ADALAT. Patient recovered.

Velcade Side Effects Report #4685606-7
Velcade side effect was reported by a Physician from on May 20, 2005. Female patient, 68 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased, bronchiectasis, decreased appetite, diarrhoea. Velcade dosage: unknown. During the same period patient was treated with BONALON, GASTER OD, MUCOSTA, ALFAROL, LOXONIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4690068-X
Velcade side effect was reported by a Physician from on May 31, 2005. Female patient, 68 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood creatine phosphokinase increased, blood creatinine increased, blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased. Velcade dosage: 1.94 MG, 2/WEEK, IV BOLUS. During the same period patient was treated with BONALON, GASTER OD, MUCOSTA, ALFAROL, LOXONIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4728244-X
Velcade side effect was reported by a Physician from JAPAN on July 12, 2005. Female patient, 68 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acidosis, acute respiratory distress syndrome, adrenal insufficiency, alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection

, blood bicarbonate decreased, blood calcium decreased, blood creatine phosphokinase increased. Velcade dosage: 1.94 MG, 2/WEEK, IV BOLU; 1.91 MG, 2/WKK, IV BOLUS. During the same period patient was treated with BONALON, GASTER OD, MUCOSTA, ALFARCOL, LOXONIN. Patient was hospitalized. Patient died on 07/12/2005.

Velcade Side Effects Report #4744332-6
Velcade side effect was reported by a Physician from JAPAN on July 27, 2005. Female patient, 68 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood bicarbonate decreased, blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased, bronchiectasis. Velcade dosage: 1.94 MG, 2/WEEK/IV BOLUS; 1.91 MG, 2/WEEK, IV BOLUS. During the same period patient was treated with BONALON, GASTER OD, MUCOSTA, ALFAROL, LOXONIN, AMINOFLUID, VITAJECT. Patient was hospitalized. Patient died on 07/12/2005.

Velcade Side Effects Report #4850916-7
Velcade side effect was reported by a Physician from SWITZERLAND on Nov 22, 2005. Male patient, 68 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, liver disorder. Velcade dosage: 2.50 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with OXYCONTIN, ESCITALOPRAM OXALATE, CAPTORIL, MORPHINE. Patient recovered.

Velcade Side Effects Report #5123305-8
Velcade side effect was reported by a Physician from JAPAN on Sept 21, 2006. Female patient, 67 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, depressed level of consciousness, hepatic failure, incoherent, interleukin level increased, metastases to liver. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died on 09/01/2005.

Velcade Side Effects Report #5139676-2
Velcade side effect was reported by a Physician from JAPAN on Oct 11, 2006. Female patient, 67 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, depressed level of consciousness, incoherent, interleukin level increased, metastases to liver, oesophageal cancer metastatic. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died on 09/01/2005.

Velcade Side Effects Report #5504715-3
Velcade side effect was reported by a Physician from JAPAN on Oct 19, 2007. Male patient, 67 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood uric acid increased, condition aggravated, disease progression, gastrointestinal haemorrhage, haemorrhagic diathesis, multiple myeloma

. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, BETAMETHASONE, ORGARAN. Patient died on 09/10/2007.

Velcade Side Effects Report #4748413-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2005. Male patient, 67 years of age, weighting 179.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hypoaesthesia, pyrexia, rhinorrhoea, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, PRAVACHOL, COLCHICINE. Patient recovered.

Velcade Side Effects Report #4753318-7
Velcade side effect was reported by a Pharmacist from UNITED STATES on June 01, 2005. Female patient, 67 years of age, weighting 170.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aggression, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood calcium increased, blood lactate dehydrogenase increased, blood urea increased, communication disorder, confusional state. Velcade dosage: 1.63 MG, UNK, IV BOLUS. During the same period patient was treated with DECADRON, AREDIA, VITAMINS, LOZOL, CLONIDINE, ALBUTEROL, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4931318-1
Velcade side effect was reported by a Pharmacist from UNITED STATES on June 01, 2005. Female patient, 67 years of age, weighting 170.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal pain

, aggression, alanine aminotransferase increased, anion gap increased, aspartate aminotransferase increased, base excess increased, blood alkaline phosphatase increased, blood calcium decreased. Velcade dosage: 1.63 MG, IV BOLUS. During the same period patient was treated with DECADRON SRC, AREDIA, VITMAINS, LOZOL, CLONIDINE, POTASSIUM CHLORIDE, ALBUTEROL, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6029108-4
Velcade side effect was reported by a Physician from JAPAN on Dec 24, 2008. Female patient, 66 years of age, weighting 101.4 lb, was diagnosed with multiple myeloma

, blood lactate dehydrogenase increased and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, cardiac failure congestive, cardiomegaly, constipation

, diarrhoea, dry skin, epistaxis, fluid overload, gastrointestinal haemorrhage. Velcade dosage: 1.30 MG/M2, INTRAVENOUS; 1.7 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, LOPEMIN, VEEN D, VITAMEDIN INTRAVENOUS, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 12/27/2007.

Velcade Side Effects Report #4610309-4
Velcade side effect was reported by a Health Professional from on Feb 16, 2005. Female patient, 66 years of age, weighting 218.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, azotaemia, beta 2 microglobulin increased, blood bilirubin increased, blood creatinine increased, blood glucose increased, blood potassium increased, haematocrit decreased, impaired healing. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, AREDIA. Patient recovered.

Velcade Side Effects Report #4620440-5
Velcade side effect was reported by a Health Professional from on Mar 10, 2005. Female patient, 66 years of age, weighting 20.50 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, azotaemia, beta 2 microglobulin increased, blood creatine increased, blood glucose increased, blood potassium increased, haematocrit decreased, impaired healing. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, AREDIA. Patient recovered.

Velcade Side Effects Report #4688374-8
Velcade side effect was reported by a Physician from on May 24, 2005. Male patient, 66 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal adhesions, abdominal distension, abdominal pain

, activated partial thromboplastin time prolonged, aspartate aminotransferase increased, atrioventricular block complete, blood albumin decreased, blood amylase increased, blood bicarbonate decreased. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, FENTANYL, CYCLIZINE, LANSOPRAZOLE, CODEINE PHOSPHATE, ZOPICLONE, PIRITON, AMITRIPTYLINE. Patient was hospitalized. Patient died on 11/03/2004.

Velcade Side Effects Report #4774963-9
Velcade side effect was reported by a Physician from NETHERLANDS on Sept 05, 2005. Female patient, 66 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood sodium decreased, haemoglobin decreased, hepatic function abnormal, hyperglycaemia. Velcade dosage: 2.60 + 2.00MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with AMARYL, ACTOS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4975015-5
Velcade side effect was reported by a Physician from UNITED KINGDOM on Mar 27, 2006. Male patient, 66 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain

, activated partial thromboplastin time prolonged, aspartate aminotransferase increased, atrioventricular block complete, blood albumin decreased, blood amylase increased, blood bicarbonate decreased, blood bilirubin increased. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, FENTANYL, CYCLIZINE, LANSOPRAZOLE, CODEINE PHOSPHATE, ZOPICLONE, PIRITON, AMITRIPTYLINE. Patient was hospitalized. Patient died on 11/03/2004.

Velcade Side Effects Report #5030929-5
Velcade side effect was reported by a Physician from CANADA on June 06, 2006. Male patient, 66 years of age, weighting 172.2 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood pressure systolic increased. Velcade dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with ATORVASTATIN CALCIUM, VITAMIN E, ZOPICLONE, ACETAMINOPHEN, MEPERIDINE, IMIPENEM, CEFOTAXIME, COLACE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5268771-2
Velcade side effect was reported by a Physician from JAPAN on Mar 01, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, duodenal ulcer haemorrhage, dysgeusia, malaise, thrombocytopenia, vomiting. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5288286-5
Velcade side effect was reported by a Physician from JAPAN on Mar 20, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma

, thrombocytopenia. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5302221-2
Velcade side effect was reported by a Physician from JAPAN on Apr 02, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, duodenal ulcer, duodenal ulcer haemorrhage, dysgeusia, malaise, thrombocytopenia, vomiting. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DECADRON, SULFAMETHOXAZOLE, ZANTAC, SELBEX, MAGNESIUM OXIDE, ITRACONAZOLE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5390874-2
Velcade side effect was reported by a Physician from JAPAN on July 04, 2007. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, herpes zoster, hypoaesthesia, nausea

, platelet count decreased, urinary tract infection

. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PIMPERAN, SULFAMETHOXAZOLE, CIPROXAN, BASEN, AMARYL, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5429342-8
Velcade side effect was reported by a Physician from JAPAN on Aug 16, 2007. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, herpes zoster, hypoaesthesia, nausea

, platelet count decreased, urinary tract infection

. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, BAKTAR, CIPROXAN, BASEN, AMARYL, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5429342-8
Velcade side effect was reported by a Physician from JAPAN on Aug 16, 2007. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, herpes zoster, hypoaesthesia, nausea

, platelet count decreased, urinary tract infection

. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, BAKTAR, CIPROXAN, BASEN, AMARYL, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5617250-9
Velcade side effect was reported by a Physician from JAPAN on Jan 24, 2008. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, hepatic function abnormal, herpes zoster, hypoaesthesia, nausea

, platelet count decreased, pyrexia, urinary tract infection

. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, BAKTAR, CIPROFLOXACIN, BASEN, AMARYL, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5804284-4
Velcade side effect was reported by a Physician from JAPAN on June 25, 2008. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood urea increased, hepatic function abnormal, herpes zoster, hypoaesthesia, nausea

, platelet count decreased. Velcade dosage: 1.5 MG, INTRAVENOUS; 1.1 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CIPROXAN, BASEN, AMARYL, LANSOPRAZOLE. Patient recovered.

Velcade Side Effects Report #5921271-6
Velcade side effect was reported by a Physician from JAPAN on Sept 30, 2008. Male patient, 65 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood chloride increased, blood lactate dehydrogenase, cardiac failure, clavicle fracture, condition aggravated, coronary artery stenosis, diarrhoea, humerus fracture. Velcade dosage: 2.10 MG, INTRAVENOUS; 1.6 MEQ, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SELBEX, WARFARIN POTASSIUM, BUCOLOME, BISOPROLOL FUMARATE, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6009123-7
Velcade side effect was reported by a Physician from JAPAN on Dec 02, 2008. Male patient, 65 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, atrial fibrillation

, blood chloride increased, blood lactate dehydrogenase increased, cardiac failure, clavicle fracture, condition aggravated, coronary artery stenosis. Velcade dosage: 2.10 MG, INTRAVENOUS; 1.6 MEQ, INTRAVENOS; 20 MG, ORAL. During the same period patient was treated with DEXAMETHASONE, SELBEX, WARFARIN, PARAMIDIN, BISOPROLOL FUMARATE, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5584725-0
Velcade side effect was reported by a Physician from JAPAN on Dec 19, 2007. Female patient, 64 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anaesthesia, anal erosion, arterial thrombosis limb, aspartate aminotransferase increased, back pain

, blood amylase increased, blood calcium decreased, blood lactate dehydrogenase increased. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ADONA, TRANSAMIN, DOPAMINE HYDROCHLORIDE, MEROPEN, FAMOTIDINE, CLARITHROMYCIN. Patient died on 12/25/2006.

Velcade Side Effects Report #5843026-3
Velcade side effect was reported by a Physician from JAPAN on July 29, 2008. Female patient, 64 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood albumin decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, blood uric acid increased, cardiac failure. Velcade dosage: 2.1 MG UNK INTRAVENOUS. During the same period patient was treated with PENTAMIDINE, FRAGMIN, DEXAMETHASONE, RED BLOOD CELLS, PLATELETS, GANCICLOVIR, LASIX, SOLDACTONE. Patient died on 04/15/2007.

Velcade Side Effects Report #6029110-2
Velcade side effect was reported by a Physician from JAPAN on Dec 25, 2008. Female patient, 64 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma

, hepatitis c

and was treated with Velcade. After drug was administered, patient experienced the following side effects: adenoviral haemorrhagic cystitis, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, cardiac failure. Velcade dosage: 2.1 MG, INTRAVENOUS. During the same period patient was treated with GANCICLOVIR, RIBAVIRIN, DEXAMETHASONE, RED BLOOD CELLS, PLATELETS, LASIX, SOLDACTONE, REMINARON. Patient died on 04/15/2007.

Velcade Side Effects Report #5691921-0
Velcade side effect was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, 63 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma

, platelet count decreased. Velcade dosage: 2.00 MG UNK INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, VANCOMYCIN, ADONA, MUCOSOLVAN, LANSOPRAZOLE, ITRACONAZOLE, MAGNESIUM OXIDE, OXYCONTIN. Patient died on 01/14/2008.

Velcade Side Effects Report #5714116-0
Velcade side effect was reported by a Physician from JAPAN on Apr 09, 2008. Male patient, 63 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood amylase decreased, blood lactate dehydrogenase decreased, blood sodium decreased, diarrhoea, disease progression, dizziness

. Velcade dosage: 1.30 MG/M2,; 1.6 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, AMLODIPINE BESYLATE, ZOVIRAX, ALLOPURINOL, OMEPRAL, MAGNESIUM OXIDE. Patient was hospitalized. Patient died.

Velcade Side Effects Report #5753100-8
Velcade side effect was reported by a Physician from UNITED STATES on May 12, 2008. Male patient, 63 years of age, weighting 220.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood creatinine increased, blood potassium increased, blood urea increased, diarrhoea, escherichia urinary tract infection. Velcade dosage: 1.6 MG/M2, INTRAVENOUS. During the same period patient was treated with REVLIMID, VITAMIN D, DURAGESIC, VITAMIN B12, DILAUDID, ATROVENT, ALBUTEROL, PULMICORT. Patient was hospitalized. Patient died on 03/05/2008.

Velcade Side Effects Report #5775304-0
Velcade side effect was reported by a Physician from JAPAN on June 04, 2008. Male patient, 63 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, disease progression, platelet count decreased, tumour lysis syndrome. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, VANCOMYCIN, ADONA, MUCOSOLVAN, LANSOPRAZOLE, ITRACONAZOLE, MAGNESIUM OXIDE, OXYCONTIN. Patient died on 01/14/2008.

Velcade Side Effects Report #5783001-0
Velcade side effect was reported by a Physician from JAPAN on June 12, 2008. Male patient, 63 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood uric acid increased, disease progression, platelet count decreased, tumour lysis syndrome. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, VANCOMYCIN, ADONA, MUCOSOLVAN, LANSOPRAZOLE, ITRACONAZOLE, MAGNESIUM OXIDE, OXYCONTIN. Patient died on 01/14/2008.

Velcade Side Effects Report #5989644-3
Velcade side effect was reported by a Physician from JAPAN on Nov 26, 2008. Male patient, 63 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood pressure decreased, tumour lysis syndrome. Velcade dosage: 1 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 11/20/2008.

Velcade Side Effects Report #6026172-3
Velcade side effect was reported by a Physician from JAPAN on Dec 18, 2008. Male patient, 63 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood pressure decreased, hypoxia, liver disorder, multi-organ failure, renal impairment, tumour lysis syndrome. Velcade dosage: 1 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON, CIPROFLOXACIN, ACYCLOVIR, AMBISOME, PLATELETS. Patient died on 11/20/2008.

Velcade Side Effects Report #4870815-4
Velcade side effect was reported by a Physician from JAPAN on Dec 14, 2005. Female patient, 63 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood chloride decreased, blood lactate dehydrogenase increased, blood ph increased, blood sodium decreased, blood urea increased, bronchitis

, bronchopneumonia. Velcade dosage: 1.30; 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with FOSAMAX, LOXONIN, DICLOFENAC. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4889606-3
Velcade side effect was reported by a Physician from JAPAN on Jan 06, 2006. Female patient, 63 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood chloride decreased, blood lactate dehydrogenase increased, blood ph increased, blood sodium decreased, bronchopneumonia, dehydration, enterocolitis. Velcade dosage: unknown. During the same period patient was treated with FOSAMAX, SULFAMETHOXAZOLE, BROTIZOLAM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4978891-5
Velcade side effect was reported by a Physician from JAPAN on Mar 29, 2006. Female patient, 63 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood chloride decreased, blood lactate dehydrogenase increased, blood ph increased, blood sodium decreased, bronchopneumonia, candidiasis. Velcade dosage: unknown. During the same period patient was treated with FOSAMAX, SULFAMETHOXAZOLE, BROTIZOLAM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5656242-0
Velcade side effect was reported by a Physician from JAPAN on Feb 25, 2008. Male patient, 62 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, constipation

, disease progression, dysphonia, epistaxis, hepatic function abnormal, hypotension, laboratory test abnormal, neuropathy peripheral. Velcade dosage: 2.20 MG, INTRAVENOUS, 1.70 MG, INTRAVENOUS, 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, CEFAZOLIN, EXACIN, PRODIF, ALFAROL. Patient died on 08/20/2007.

Velcade Side Effects Report #5692800-5
Velcade side effect was reported by a Physician from JAPAN on Mar 21, 2008. Female patient, 61 years of age, weighting 90.39 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorectal disorder, aspartate aminotransferase increased, bladder disorder, disease progression, hepatic neoplasm, lymphadenopathy, paraplegia, platelet count decreased. Velcade dosage: 1.7 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE PHOSPHATE, PREDNISOLONE, DECADRON, ALPRAZOLAM, LENDORM, SELBEX, MAGNESIUM OXIDE, BIOFERMIN R. Patient died on 04/20/2007.

Velcade Side Effects Report #4693865-X
Velcade side effect was reported by a Health Professional from on June 02, 2005. Female patient, 61 years of age, weighting 145.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased. Velcade dosage: 1.80 MG, UNK, IV BOLUS. Patient recovered.

Velcade Side Effects Report #5128001-9
Velcade side effect was reported by a Physician from JAPAN on Sept 29, 2006. Female patient, 60 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, depressed level of consciousness, interleukin level increased, pyrexia, tumour lysis syndrome, vomiting. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5622911-1
Velcade side effect was reported by a Physician from JAPAN on Jan 28, 2008. Male patient, 60 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma

, pain

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, disease progression, diverticulum intestinal haemorrhagic, haemoglobin decreased, malaise, melaena, multiple myeloma

. Velcade dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with ETODOLAC, PREDNISOLONE, TEGRETOL, MEXITIL, MAGNESIUM OXIDE, FAMOTIDINE, ALLOPURINOL, FENTANYL. Patient died on 01/04/2008.

Velcade Side Effects Report #5319685-0
Velcade side effect was reported by a Physician from JAPAN on Apr 20, 2007. Male patient, 59 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, ascites, aspartate aminotransferase increased, blood lactate dehydrogenase increased, diarrhoea, haematemesis, haemorrhagic diathesis, hypoalbuminaemia, malaise. Velcade dosage: 2.20 MG. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE, BIOFERMIN, PRIMPERAN, LOPERAMIDE, NOVAMIN, BUMINATE. Patient died on 04/21/2007.

Velcade Side Effects Report #5420123-8
Velcade side effect was reported by a Physician from JAPAN on Aug 03, 2007. Male patient, 59 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, ascites, aspartate aminotransferase increased, blood lactate dehydrogenase increased, diarrhoea, haematemesis, haemorrhagic diathesis, hypoalbuminaemia, malaise. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE, BIOFERMIN, PRIMPERAN, LOPERAMIDE, NOVAMIN, BUMINATE. Patient died on 04/21/2007.

Velcade Side Effects Report #4736780-5
Velcade side effect was reported by a Health Professional from UNITED STATES on July 20, 2005. Male patient, 59 years of age, weighting 164.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain

, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, disease progression, fall

, haematocrit decreased, haemodialysis, haemoglobin decreased. Velcade dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, CAMPHOR, DOCUSATE, METOPROLOL TARTRATE, NEPHRO, OXYCODONE, SENNA, SEVELAMER. Patient was hospitalized. Patient died on 03/28/2005.

Velcade Side Effects Report #5488834-6
Velcade side effect was reported by a Physician from JAPAN on Oct 11, 2007. Male patient, 58 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood pressure decreased, blood urea increased, cardiac arrest

, tumour lysis syndrome. Velcade dosage: 1.80 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5862422-1
Velcade side effect was reported by a Physician from JAPAN on Aug 18, 2008. Male patient, 58 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma

, bipolar disorder

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, c-reactive protein increased, constipation

, fungal infection

, hyperglycaemia, platelet count decreased, road traffic accident. Velcade dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with DECADRON, TASMOLIN, LULLAN, PENFILL N, PENFILL R, LORAZEPAM, LITHIUM CARBONATE, NITRAZEPAM. Patient recovered.

Velcade Side Effects Report #4847352-6
Velcade side effect was reported by a Physician from GERMANY on Nov 24, 2005. Male patient, 58 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, cardiac failure, cardio-respiratory arrest, coagulation test abnormal, condition aggravated, dehydration. Velcade dosage: 2.00 MG IV BOLUS. During the same period patient was treated with NORVASC, ALLOPURINOL, LASIX, NEXIUM, VERGENTAN, METOPROLOL SUCCINATE, OMEPRAZOLE, TRAMADOL. Patient was hospitalized. Patient died on 03/26/2005.

Velcade Side Effects Report #5201627-X
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Dec 20, 2006. Female patient, 57 years of age, weighting 202.8 lb, was diagnosed with multiple myeloma

, transaminases increased. Velcade dosage: 3.50 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5162878-6
Velcade side effect was reported by a Physician from UNITED STATES on Nov 10, 2006. Female patient, 56 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood potassium decreased, delusion, hallucination, visual, intervertebral disc compression, mania. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL, DEXAMETHASONE, OXYCODONE, POTASSIUM, LASIX, PROTONIX, ACYCLOVIR, LOVENOX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5551277-0
Velcade side effect was reported by a Physician from JAPAN on Nov 27, 2007. Male patient, 56 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood sodium decreased, diarrhoea, diverticulitis, dysphonia, gamma-glutamyltransferase increased. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DECADRON, LANSOPRAZOLE, FLUCONAZOLE, OXYCONTIN, LAXOBERON, BAKTAR, MAGNESIUM OXIDE, ZOMETA. Patient recovered.

Velcade Side Effects Report #5689711-8
Velcade side effect was reported by a Physician from JAPAN on Mar 25, 2008. Male patient, 56 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma

. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with SENNOSIDE, ACYCLOVIR, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PANTOSIN, MAGNESIUM OXIDE, FENTANYL, LAMIVUDINE. Patient died on 08/25/2007.

Velcade Side Effects Report #5701455-2
Velcade side effect was reported by a Physician from JAPAN on Mar 26, 2008. Male patient, 56 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood sodium decreased, c-reactive protein increased, chest discomfort, diarrhoea, disease progression. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DECADRON, LANSOPRAZOLE, FLUCONAZOLE, OXYCONTIN, LAXOBERON, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MAGNEXIUM OXIDE, ZOMETA. Patient died on 12/15/2007.

Velcade Side Effects Report #5746696-3
Velcade side effect was reported by a Physician from JAPAN on May 09, 2008. Male patient, 56 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma

. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with SENNOSIDE A, ACYCLOVIR, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PANTOSIN, MAGNESIUM OXIDE, FENTANYL, LAMIVUDINE. Patient recovered.

Velcade Side Effects Report #5775302-7
Velcade side effect was reported by a Physician from JAPAN on June 02, 2008. Male patient, 56 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, diarrhoea, disease progression, dysstasia, gait disturbance, hypoaesthesia. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with SENNOSIDE A, ACYCLOVIR, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PANTOSIN, MAGNESIUM OXIDE, FENTANYL, LAMIVUDINE. Patient died on 08/25/2007.

Velcade Side Effects Report #5851871-3
Velcade side effect was reported by a Physician from JAPAN on Aug 08, 2008. Male patient, 56 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma

Velcade and aspartate aminotransferase increased

SideEffects101.com

Velcade and aspartate aminotransferase increased Patient Reports March 15, 2010

side effects of Velcade